Do analysts recommend BRTX or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer BRTX or ATPC?

In the previous week, Agape ATP had 1 more articles in the media than Biorestorative Therapies. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Biorestorative Therapies. Agape ATP's average media sentiment score of 0.98 beat Biorestorative Therapies' score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biorestorative Therapies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ADVB or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ATPC or ACON?

Aclarion has a consensus price target of $7.50, suggesting a potential upside of 140.38%. Given Aclarion's stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, ATPC or ACON?

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 2.55 -$2.28M -$1.33 N/A Aclarion $80K 95.94 -$7.23M -$9.03 N/A

Is ATPC or ACON more profitable?

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Agape ATP -125.89% -8.43% -7.75% Aclarion -10,320.51% -54.41% -51.71%

Does the media favor ATPC or ACON?

In the previous week, Agape ATP had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Aclarion. Agape ATP's average media sentiment score of 0.98 beat Aclarion's score of 0.00 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aclarion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BGLC or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend MGRX or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mangoceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MGRX or ATPC more profitable?

Agape ATP has a net margin of -125.89% compared to Mangoceuticals' net margin of -4,639.13%. Agape ATP's return on equity of -8.43% beat Mangoceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Mangoceuticals -4,639.13% -112.00% -104.96% Agape ATP -125.89% -8.43% -7.75%

Agape ATP (ATPC) Competitors

$3.88 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$4.25 +0.37 (+9.48%)

As of 06/18/2026 08:00 PM Eastern

Compare

ATPC vs. BRTX, ADVB, ACON, BGLC, and MGRX

Should you buy Agape ATP stock or one of its competitors? MarketBeat compares Agape ATP with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agape ATP include Biorestorative Therapies (BRTX), Advanced Biomed (ADVB), Aclarion (ACON), BioNexus Gene Lab (BGLC), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry.

How does Agape ATP compare to Biorestorative Therapies?

Biorestorative Therapies (NASDAQ:BRTX) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

Biorestorative Therapies has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.05, indicating that its share price is 95% less volatile than the broader market.

In the previous week, Agape ATP had 1 more articles in the media than Biorestorative Therapies. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Biorestorative Therapies. Agape ATP's average media sentiment score of 0.98 beat Biorestorative Therapies' score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biorestorative Therapies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Biorestorative Therapies. Agape ATP is trading at a lower price-to-earnings ratio than Biorestorative Therapies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biorestorative Therapies	$360K	28.99	-$14.24M	-$1.07	N/A
Agape ATP	$1.52M	2.55	-$2.28M	-$1.33	N/A

Agape ATP has a net margin of -125.89% compared to Biorestorative Therapies' net margin of -3,088.27%. Agape ATP's return on equity of -8.43% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%
Agape ATP	-125.89%	-8.43%	-7.75%

69.4% of Biorestorative Therapies shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 13.6% of Biorestorative Therapies shares are owned by insiders. Comparatively, 2.0% of Agape ATP shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Agape ATP beats Biorestorative Therapies on 7 of the 13 factors compared between the two stocks.

How does Agape ATP compare to Advanced Biomed?

Advanced Biomed (NASDAQ:ADVB) and Agape ATP (NASDAQ:ATPC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Advanced Biomed has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.05, meaning that its stock price is 95% less volatile than the broader market.

Advanced Biomed has a net margin of 0.00% compared to Agape ATP's net margin of -125.89%. Advanced Biomed's return on equity of 87.74% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Agape ATP	-125.89%	-8.43%	-7.75%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has higher revenue and earnings than Advanced Biomed. Agape ATP is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.06
Agape ATP	$1.52M	2.55	-$2.28M	-$1.33	N/A

In the previous week, Agape ATP had 2 more articles in the media than Advanced Biomed. MarketBeat recorded 2 mentions for Agape ATP and 0 mentions for Advanced Biomed. Agape ATP's average media sentiment score of 0.98 beat Advanced Biomed's score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
Advanced Biomed	Neutral
Agape ATP	Positive

0.0% of Agape ATP shares are owned by institutional investors. 27.0% of Advanced Biomed shares are owned by company insiders. Comparatively, 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Advanced Biomed beats Agape ATP on 7 of the 12 factors compared between the two stocks.

How does Agape ATP compare to Aclarion?

Agape ATP (NASDAQ:ATPC) and Aclarion (NASDAQ:ACON) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

Agape ATP has higher revenue and earnings than Aclarion. Agape ATP is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	2.55	-$2.28M	-$1.33	N/A
Aclarion	$80K	95.94	-$7.23M	-$9.03	N/A

Aclarion has a consensus price target of $7.50, suggesting a potential upside of 140.38%. Given Aclarion's stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Agape ATP had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Aclarion. Agape ATP's average media sentiment score of 0.98 beat Aclarion's score of 0.00 indicating that Agape ATP is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aclarion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agape ATP has a beta of 0.05, meaning that its share price is 95% less volatile than the broader market. Comparatively, Aclarion has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market.

0.0% of Agape ATP shares are held by institutional investors. Comparatively, 7.5% of Aclarion shares are held by institutional investors. 2.0% of Agape ATP shares are held by insiders. Comparatively, 0.0% of Aclarion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Agape ATP has a net margin of -125.89% compared to Aclarion's net margin of -10,320.51%. Agape ATP's return on equity of -8.43% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-125.89%	-8.43%	-7.75%
Aclarion	-10,320.51%	-54.41%	-51.71%

Summary

Agape ATP beats Aclarion on 9 of the 16 factors compared between the two stocks.

How does Agape ATP compare to BioNexus Gene Lab?

BioNexus Gene Lab (NASDAQ:BGLC) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

BioNexus Gene Lab has a beta of 4.06, suggesting that its stock price is 306% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.05, suggesting that its stock price is 95% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BioNexus Gene Lab has a net margin of -54.70% compared to Agape ATP's net margin of -125.89%. Agape ATP's return on equity of -8.43% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-54.70%	-37.43%	-32.88%
Agape ATP	-125.89%	-8.43%	-7.75%

Agape ATP has lower revenue, but higher earnings than BioNexus Gene Lab. Agape ATP is trading at a lower price-to-earnings ratio than BioNexus Gene Lab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43M	0.85	-$2.98M	-$1.48	N/A
Agape ATP	$1.52M	2.55	-$2.28M	-$1.33	N/A

In the previous week, Agape ATP had 2 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for Agape ATP and 0 mentions for BioNexus Gene Lab. Agape ATP's average media sentiment score of 0.98 beat BioNexus Gene Lab's score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
BioNexus Gene Lab	Neutral
Agape ATP	Positive

18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by company insiders. Comparatively, 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Agape ATP beats BioNexus Gene Lab on 8 of the 13 factors compared between the two stocks.

How does Agape ATP compare to Mangoceuticals?

Mangoceuticals (NASDAQ:MGRX) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

Agape ATP has higher revenue and earnings than Mangoceuticals. Agape ATP is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mangoceuticals	$460K	11.82	-$20.64M	-$1.49	N/A
Agape ATP	$1.52M	2.55	-$2.28M	-$1.33	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mangoceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has a net margin of -125.89% compared to Mangoceuticals' net margin of -4,639.13%. Agape ATP's return on equity of -8.43% beat Mangoceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mangoceuticals	-4,639.13%	-112.00%	-104.96%
Agape ATP	-125.89%	-8.43%	-7.75%

In the previous week, Agape ATP had 2 more articles in the media than Mangoceuticals. MarketBeat recorded 2 mentions for Agape ATP and 0 mentions for Mangoceuticals. Agape ATP's average media sentiment score of 0.98 beat Mangoceuticals' score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
Mangoceuticals	Neutral
Agape ATP	Positive

Mangoceuticals has a beta of 2.27, indicating that its stock price is 127% more volatile than the broader market. Comparatively, Agape ATP has a beta of 0.05, indicating that its stock price is 95% less volatile than the broader market.

56.7% of Mangoceuticals shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by company insiders. Comparatively, 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Agape ATP beats Mangoceuticals on 8 of the 13 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATPC vs. The Competition

Export

Metric	Agape ATP	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.88M	$8.34B	$6.65B	$12.60B
Dividend Yield	N/A	2.55%	2.68%	5.81%
P/E Ratio	-2.92	15.57	24.75	24.42
Price / Sales	2.55	7.36	529.30	111.09
Price / Cash	N/A	17.32	27.92	37.84
Price / Book	0.17	3.29	10.81	6.60
Net Income	-$2.28M	$226.25M	$3.57B	$337.10M
7 Day Performance	34.26%	-1.92%	0.72%	0.83%
1 Month Performance	8.08%	-2.90%	0.41%	2.25%
1 Year Performance	-95.06%	0.83%	29.34%	36.14%

Agape ATP Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATPC Agape ATP	0.6588 of 5 stars	$3.88 flat	N/A	-95.1%	$3.88M	$1.52M	N/A	40	News Coverage Analyst Downgrade Gap Down High Trading Volume
BRTX Biorestorative Therapies	0.4096 of 5 stars	$0.40 +13.1%	N/A	-74.1%	$9M	$360K	N/A	7	News Coverage Gap Down
ADVB Advanced Biomed	1.1362 of 5 stars	$4.75 +5.3%	N/A	N/A	$7.45M	N/A	0.99	40
ACON Aclarion	3.0602 of 5 stars	$3.11 +5.8%	$7.50 +141.2%	-56.8%	$7.24M	$80K	N/A	7	Analyst Upgrade Gap Up High Trading Volume
BGLC BioNexus Gene Lab	0.3224 of 5 stars	$2.52 -3.1%	N/A	-9.1%	$6.28M	$7.43M	N/A	30	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATPC) was last updated on 6/22/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agape ATP (ATPC) Competitors

ATPC vs. BRTX, ADVB, ACON, BGLC, and MGRX

How does Agape ATP compare to Biorestorative Therapies?

Summary

How does Agape ATP compare to Advanced Biomed?

Summary

How does Agape ATP compare to Aclarion?

Summary

How does Agape ATP compare to BioNexus Gene Lab?

Summary

How does Agape ATP compare to Mangoceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agape ATP (ATPC) Competitors

ATPC vs. BRTX, ADVB, ACON, BGLC, and MGRX

How does Agape ATP compare to Biorestorative Therapies?

Which has more volatility & risk, BRTX or ATPC?

Does the media prefer BRTX or ATPC?

Do analysts recommend BRTX or ATPC?

Which has stronger valuation and earnings, BRTX or ATPC?

Is BRTX or ATPC more profitable?

Do institutionals and insiders believe in BRTX or ATPC?

Summary

How does Agape ATP compare to Advanced Biomed?

Which has more risk and volatility, ADVB or ATPC?

Is ADVB or ATPC more profitable?

Do analysts rate ADVB or ATPC?

Which has higher valuation and earnings, ADVB or ATPC?

Does the media prefer ADVB or ATPC?

Do insiders & institutionals hold more shares of ADVB or ATPC?

Summary

How does Agape ATP compare to Aclarion?

Which has better earnings and valuation, ATPC or ACON?

Do analysts prefer ATPC or ACON?

Does the media favor ATPC or ACON?

Which has more risk and volatility, ATPC or ACON?

Do institutionals & insiders have more ownership in ATPC or ACON?

Is ATPC or ACON more profitable?

Summary

How does Agape ATP compare to BioNexus Gene Lab?

Which has more volatility and risk, BGLC or ATPC?

Do analysts prefer BGLC or ATPC?

Is BGLC or ATPC more profitable?

Which has stronger earnings & valuation, BGLC or ATPC?

Does the media favor BGLC or ATPC?

Do institutionals & insiders have more ownership in BGLC or ATPC?

Summary

How does Agape ATP compare to Mangoceuticals?

Which has better valuation and earnings, MGRX or ATPC?

Do analysts recommend MGRX or ATPC?

Is MGRX or ATPC more profitable?

Does the media favor MGRX or ATPC?

Which has more risk and volatility, MGRX or ATPC?

Do institutionals and insiders believe in MGRX or ATPC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools